StructurE-unbiased Library for Exploratory disCovery of Targets
StructurE-unbiased Library for Exploratory disCovery of Targets
“The SELECT library aims to include a wide range of different types of chemistries, including non-drug-like molecules, increasing the chance of disruptive discoveries”
SELECT Compound Library
A structure-unbiased chemical toolbox for antiviral and anticancer target discovery.
The SELECT compound library is designed to explore uncharted chemical space. Unlike traditional drug libraries, SELECT embraces structural diversity and includes both drug-like and non-drug-like molecules to maximize the potential for disruptive discoveries.
What Makes SELECT Unique?
Phenotypic-first approach
No bias toward known targets.
High chemical diversity
Includes heterocycles, nucleos(t)ides, natural products, carbohydrates, macrocycles and peptidomimetics. Classical drug-like molecules as well as unconventional structures and novel scaffolds are part of SELECT.
Academic-first philosophy
Built for discovery, not just development.
Current Size and Diversity
30,000+
Compounds screened (2015–2024)
181
Contributing chemists from
32
Countries
8493
Antivirally active compounds
340
Antitumoral compounds with known mechanisms